Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...
Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be caused by a variety of factors, including metabolic dysfunction-associated ...
Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back: Nottingham, UK Saturday, April 4, 2026, 18:00 Hrs [IST] Sygnature Discovery, a le ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results